Accustem Sciences ACUT
OTC ACUT
$0.16 -0.06 (-28.89%)
As of: Aug 21, 2026 · 2:06 PM EDT

Accustem Sciences (ACUT) EPS (Diluted) Growth (3y) (2025 - 2026)

Accustem Sciences (ACUT) EPS (Diluted) Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.01%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.90%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 61.64%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 18.44%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 36.83%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.39%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -26.90%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 67.51%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -36.81%
10 Accustem Sciences 2.57 Mn 2.56 Mn - 21.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 25.61%
Dec 31, 2025 27.56%
Sep 30, 2025 32.05%
Jun 30, 2025 35.96%